Mismatch Repair-deficient (dMMR)
Also known as: Mismatch Repair Deficiency / Mismatch Repair Deficient (dMMR)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09035 | Nivolumab | Programmed cell death protein 1 | target |
| DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00958 | Carboplatin | 0 | Terminated | 1 |
| DB01229 | Paclitaxel | 0 | Terminated | 1 |
| DB14922 | Tislelizumab | 0 | Terminated | 1 |
| DB16417 | Geptanolimab | 1 | Completed | 1 |
| DB06186 | Ipilimumab | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB16680 | Cadonilimab | 1 / 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB11945 | Avelumab | 2 | Active Not Recruiting | 1 |
| DB17465 | CD-16 NK-92 cells | 2 | Active Not Recruiting | 1 |
| DB16680 | Cadonilimab | 2 | Not Yet Recruiting | 1 |
| DB00482 | Celecoxib | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB14825 | Danvatirsen | 2 | Active Not Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 2 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB16479 | Inbakicept | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB15043 | Toripalimab | 2 | Recruiting | 2 |
| DB14776 | Camrelizumab | Not Available | Recruiting | 1 |